103 related articles for article (PubMed ID: 2139918)
1. Splanchnic removal of human alpha-atrial natriuretic peptide in humans: enhancement after food intake.
Henriksen JH; Bendtsen F; Gerbes AL
Metabolism; 1990 May; 39(5):553-6. PubMed ID: 2139918
[TBL] [Abstract][Full Text] [Related]
2. Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis.
Henriksen JH; Bendtsen F; Schütten HJ; Warberg J
Am J Gastroenterol; 1990 Sep; 85(9):1155-9. PubMed ID: 2143885
[TBL] [Abstract][Full Text] [Related]
3. Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade.
Bendtsen F; Gerbes AL; Henriksen JH
Scand J Clin Lab Invest; 1993 Oct; 53(6):547-54. PubMed ID: 8265999
[TBL] [Abstract][Full Text] [Related]
4. Splanchnic disposal of human atrial natriuretic peptide in humans.
Vierhapper H; Gasic S; Nowotny P; Waldhäusl W
Metabolism; 1988 Oct; 37(10):973-5. PubMed ID: 2971855
[TBL] [Abstract][Full Text] [Related]
5. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.
Hollister AS; Rodeheffer RJ; White FJ; Potts JR; Imada T; Inagami T
J Clin Invest; 1989 Feb; 83(2):623-8. PubMed ID: 2521490
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.
Capaldo B; Gastaldelli A; Antoniello S; Auletta M; Pardo F; Ciociaro D; Guida R; Ferrannini E; Saccà L
Diabetes; 1999 May; 48(5):958-66. PubMed ID: 10331398
[TBL] [Abstract][Full Text] [Related]
7. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
Tonolo G; Richards AM; Manunta P; Troffa C; Pazzola A; Madeddu P; Towrie A; Fraser R; Glorioso N
Circulation; 1989 Oct; 80(4):893-902. PubMed ID: 2529059
[TBL] [Abstract][Full Text] [Related]
8. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
[TBL] [Abstract][Full Text] [Related]
9. EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide.
Richards AM; Wittert G; Espiner EA; Yandle TG; Frampton C; Ikram H
J Clin Endocrinol Metab; 1991 Jun; 72(6):1317-22. PubMed ID: 1827451
[TBL] [Abstract][Full Text] [Related]
10. Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure.
Moreau R; Pussard E; Brenard R; Gaudin C; Berdeaux A; Lebrec D
J Hepatol; 1991 Nov; 13(3):351-7. PubMed ID: 1839683
[TBL] [Abstract][Full Text] [Related]
11. Role of the liver in splanchnic extraction of atrial natriuretic factor in the rat.
Gerbes AL; Witthaut R; Gülberg V; Thibault G; Bilzer M; Jüngst D
Hepatology; 1992 Sep; 16(3):790-3. PubMed ID: 1387103
[TBL] [Abstract][Full Text] [Related]
12. Prazosin attenuates the natriuretic response to atrial natriuretic factor in man.
Lang CC; Choy AM; Balfour DJ; Struthers AD
Kidney Int; 1992 Aug; 42(2):433-41. PubMed ID: 1405327
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
Moe GW; Canepa-Anson R; Armstrong PW
J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
[TBL] [Abstract][Full Text] [Related]
14. Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.
Colao A; Pivonello R; Ferone D; La Tessa G; Faggiano A; Facciolli G; Di Somma C; Merola B; Lombardi G
J Endocrinol Invest; 1998 Apr; 21(4):257-62. PubMed ID: 9624601
[TBL] [Abstract][Full Text] [Related]
15. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
16. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.
Gaillard CA; Koomans HA; Rabelink TJ; Braam B; Boer P; Dorhout Mees EJ
Hypertension; 1988 Oct; 12(4):450-6. PubMed ID: 2971618
[TBL] [Abstract][Full Text] [Related]
17. Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans.
Basu R; Singh R; Basu A; Johnson CM; Rizza RA
Diabetes; 2006 Mar; 55(3):667-74. PubMed ID: 16505229
[TBL] [Abstract][Full Text] [Related]
18. Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure.
Hirsch AT; Creager MA; Dzau VJ
Am J Cardiol; 1989 Jan; 63(3):211-6. PubMed ID: 2521270
[TBL] [Abstract][Full Text] [Related]
19. Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation.
Dussaule JC; Vahanian A; Michel PL; Soullier I; Czekalski S; Acar J; Ardaillou R
Circulation; 1988 Aug; 78(2):276-85. PubMed ID: 2840222
[TBL] [Abstract][Full Text] [Related]
20. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
